Trial Profile

Protocol merck 318-00: A double-blind, placebo-controlled, randomized, parallel, clinical trial to study the effect of losartan potassium on endothelial dysfunction and insulin resistance in obese patients with impaired fasting glucose

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Jul 2012 Actual patient number changed from 153 to 53 as reported by ClinicalTrials.gov.
02 Feb 2009 Actual patient numbers (153) added as reported by ClinicalTrials.gov.
02 Feb 2009 Actual end date changed from Jul 2008 to Dec 2008 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com